𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose intensity phase III trial with ifosfamide, carboplatin, etoposide, and vincristine combined with filgastrim (CEV-Ifo + G) in patients with small-cell lung cancer (SCLC)

✍ Scribed by Hanauske, A-R; Korfel, A; Perker, M; Heinrich, B; Schwab, G; Graf, M; Depenbrock, H; Höffken, G; Kreuser, E; Thiel, E; Zwingers, T; Berdel, W


Book ID
118575567
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
221 KB
Volume
21
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES